![]()
|
|
||||||||
J. Biol. Chem., Vol. 278, Issue 40, 38675-38685, October 3, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||

From the Department of Pharmacology and Toxicology, Medical College of Wisconsin, Milwaukee, Wisconsin 53226
p21-activated protein kinases (PAKs) are a family of serine/threonine protein kinases that are activated by binding of the p21 G proteins Cdc42 or Rac. The ubiquitous PAK-2 (
-PAK) is unique among the PAK isoforms because it is also activated through proteolytic cleavage by caspases or caspase-like proteases. In response to stress stimulants such as tumor necrosis factor
or growth factor withdrawal, PAK-2 is activated as a full-length enzyme and as a proteolytic PAK-2p34 fragment. Activation of full-length PAK-2 stimulates cell survival, whereas proteolytic activation of PAK-2p34 is involved in programmed cell death. Here we provide evidence that the proapoptotic effect of PAK-2p34 is regulated by subcellular targeting and degradation by the proteasome. Full-length PAK-2 is localized in the cytoplasm, whereas the proteolytic PAK-2p34 fragment translocates to the nucleus. Subcellular localization of PAK-2 is regulated by nuclear localization and nuclear export signal motifs. A nuclear export signal motif within the regulatory domain prevents nuclear localization of full-length PAK-2. Proteolytic activation removes most of the regulatory domain and disrupts the nuclear export signal. The activated PAK-2p34 fragment contains a nuclear localization signal and translocates to the nucleus. However, levels of activated PAK-2p34 are tightly regulated through ubiquitination and degradation by the proteasome. Inhibition of degradation by blocking polyubiquitination results in significantly increased levels of PAK-2p34 and as a consequence, in stimulation of programmed cell death. Therefore, nuclear targeting and inhibition of degradation appear to be critical for stimulation of the cell death response by PAK-2p34.
Received for publication, June 18, 2003
* This work was supported by Susan G. Komen Breast Cancer Foundation Grant BCTR0100185 and a Wisconsin Breast Cancer Showhouse grant (to R. J.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
To whom correspondence should be addressed: Dept. of Biochemistry, University of Health Sciences, 1750 Independence Ave., Kansas City, MO 64106. Tel.: 816-283-2273; Fax: 816-283-2357; E-mail: rjakobi{at}uhs.edu.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
D. M. Hockenbery MMPs in Unusual Places Am. J. Pathol., October 1, 2006; 169(4): 1101 - 1103. [Full Text] [PDF] |
||||
![]() |
G. L. Vilas, M. M. Corvi, G. J. Plummer, A. M. Seime, G. R. Lambkin, and L. G. Berthiaume Posttranslational myristoylation of caspase-activated p21-activated protein kinase 2 (PAK2) potentiates late apoptotic events PNAS, April 25, 2006; 103(17): 6542 - 6547. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Belmonte, M. F. Santos, A. H. Kihara, C. Y. I. Yan, and D. E. Hamassaki Light-Induced Photoreceptor Degeneration in the Mouse Involves Activation of the Small GTPase Rac1. Invest. Ophthalmol. Vis. Sci., March 1, 2006; 47(3): 1193 - 1200. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. K. Misra, R. Deedwania, and S. V. Pizzo Binding of Activated {alpha}2-Macroglobulin to Its Cell Surface Receptor GRP78 in 1-LN Prostate Cancer Cells Regulates PAK-2-dependent Activation of LIMK J. Biol. Chem., July 15, 2005; 280(28): 26278 - 26286. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. R. Singh, C. Song, Z. Yang, and R. Kumar Nuclear Localization and Chromatin Targets of p21-activated Kinase 1 J. Biol. Chem., May 6, 2005; 280(18): 18130 - 18137. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Koeppel, C. C. McCarthy, E. Moertl, and R. Jakobi Identification and Characterization of PS-GAP as a Novel Regulator of Caspase-activated PAK-2 J. Biol. Chem., December 17, 2004; 279(51): 53653 - 53664. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Zhou, J. S. Boomer, and T.-H. Tan Protein Phosphatase 4 Is a Positive Regulator of Hematopoietic Progenitor Kinase 1 J. Biol. Chem., November 19, 2004; 279(47): 49551 - 49561. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. C. Orton, J. Ling, A. J. Waskiewicz, J. A. Cooper, W. C. Merrick, N. L. Korneeva, R. E. Rhoads, N. Sonenberg, and J. A. Traugh Phosphorylation of Mnk1 by Caspase-activated Pak2/{gamma}-PAK Inhibits Phosphorylation and Interaction of eIF4G with Mnk J. Biol. Chem., September 10, 2004; 279(37): 38649 - 38657. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |